[1]袁金壑.甲型H1N1流感预后的预判因子研究进展[J].医学信息,2019,(05):52-56.[doi:10.3969/j.issn.1006-1959.2019.05.017]
 YUAN Jin-he.Advances in the Predictive Factors of Prognosis of Influenza A H1N1[J].Medical Information,2019,(05):52-56.[doi:10.3969/j.issn.1006-1959.2019.05.017]
点击复制

甲型H1N1流感预后的预判因子研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年05期
页码:
52-56
栏目:
综述
出版日期:
2019-03-01

文章信息/Info

Title:
Advances in the Predictive Factors of Prognosis of Influenza A H1N1
文章编号:
1006-1959(2019)05-0052-05
作者:
袁金壑
(重庆医科大学附属第一医院呼吸与危重症医学科,重庆 400000)
Author(s):
YUAN Jin-he
(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400000,China)
关键词:
甲型H1N1流感预后预判因子
Keywords:
Influenza A H1N1PrognosisPredictive factor
分类号:
R511.7
DOI:
10.3969/j.issn.1006-1959.2019.05.017
文献标志码:
A
摘要:
流感病毒具有传染性强、致病力强、人群普遍易感等特点,可在人群中广泛流行,部分重症患者因呼吸衰竭、甚至多器官功能障碍死亡。2009年甲型H1N1流感病毒引起了世界范围的爆发流行造成上万人死亡,目前关于重症甲流患者死亡预判因素的文章多限于小范围回顾性的研究分析,标本量少,关注的指标较为单一。本文通过阅读国内外有关甲型H1N1流感的文献,对重症甲型H1N1流感病例的预后影响因素进行了最新的、较为全面的分析总结。
Abstract:
Influenza viruses are highly contagious, pathogenic, and susceptible to the population. They can be widely prevalent in the population. Some critically ill patients die from respiratory failure and even multiple organ dysfunction. In 2009, the H1N1 influenza virus caused a worldwide outbreak of tens of thousands of deaths. At present, the articles on the predictive factors of death in patients with severe squamous flow are mostly limited to a small-scale retrospective study, with less specimens and more attention. single. In this paper, by reading the literature on influenza A H1N1 at home and abroad, the latest and more comprehensive analysis and analysis of the prognostic factors of severe cases of influenza A H1N1 were conducted.

参考文献/References:


[1]World Health Orgqnisation (WHO).Meeting reports:WHO ad hoc scientific teleconference on the current influenza A(H1N1) situation[EB/OL].http://www.who.int/csr/disease/swineflu/en/.
[2]Zhang Y,Sun W,Svendsen ER,et al.Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis[J].Crit Care,2015,19(1):46.
[3]Rodrigo C,Leonardi-Bee J,Nguyen-Van-Tam J,et al.Corticosteroids as adjunctive therapy in the treatment of influenza[J].Cochrane Database Syst Rev,2016,7(3)C:D010406.
[4]中华人民共和国国家卫生和计划生育委员会.流行性感冒诊疗方案(2018年版)[J].中华临床感染病杂志,2018,11(1):1-5.
[5]Radigan KA,Morales-Nebreda L,Soberanes S,et al.Impaired Clearance of Influenza A Virus in Obese, Leptin Receptor Deficient Mice Is Independent of Leptin Signaling in the Lung Epithelium and Macrophages[J].PLoS One,2014,9(9):e108138.
[6]Hlavinkova L,Kristufkova Z,Mikas J.Risk factors for severe outcome of cases with pandemic influenza A(H1N1)pdm09[J].Bratisl Lek Listy,2015,116(6):389-393.
[7]Littauer EQ,Esser ES,Antao OQ,et al.H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation[J].PLoS Pathog,2017,13(11):e1006757.
[8]Periolo N,Avaro M,Czech A,et al.Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity[J].J Clin Virol,2015,64(1):52-58.
[9]Sun Y,Wang Q,Yang G,et al.Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis[J].Infect Dis (Lond),2016,48(11-12):813-822.
[10]肖卫强,周国俊,许成云,等.不同模式口鼻式吸烟诱导急性肺损伤的实验研究[J].浙江大学学报(医学版),2016,45(5):522-529.
[11]刘童,安利国,杨桂文.TRIM在病毒免疫防御机制中的作用[J].国际病毒学杂志,2012,19(2):57-60.
[12]王宗义,胡爱荣,蒋素文,等.轻症和重症甲型H1N1流感患者免疫学特征比较分析[J].中华微生物学和免疫学杂志,2013,33(9):673-676.
[13]钱永兵,谢晖,田锐.早期免疫功能麻痹在重症甲型H1N1流感中的临床意义[J].中华危重病急救医学,2017,29(7):581-585.
[14]董旭南,张南,徐佩茹,等.新疆甲型H1N1流感重症病例的临床特征分析[J].中国中西医结合急救杂志,2011,18(1):25-27.
[15]张立成,张锦前,郭利民,等.重症甲型H1N1流感并发急性呼吸窘迫综合征的临床特点及危险因素分析[J].中华实验和临床感染病杂志,2014,8(3):22-27.
[16]张梓童.重症甲型H1N1流感并发急性呼吸窘迫综合征的临床特征[J].实用临床医药杂志,2016,20(11):172-174.
[17]Bouneb R,Mellouli M,Bensoltane H,et al.Characteristics and outcome of ill Critical patients with influenza A infection[J].Pan Afr Med J,2018(29):174.
[18]李燕明,居阳,佟训靓,等.老年重症甲型H1N1流感的临床特征分析[J].国际呼吸杂志,2015,35(12):899-903.
[19]Vasileva D,Badawi A.C-reactive protein as a biomarker of severe H1N1 influenza[J].Inflamm Res,2018,68(1):39-46.
[20]张学军,张庆,邢志俐,等.重症及危重症甲型H1N1流感患者血气分析及电解质水平变化研究[J].中国全科医学,2013,6(9):2959-2961.
[21]廖海军,张中伟.全身炎症反应综合征患者血磷变化及其意义[J].航空航天医药,2006,17(1):48-49.
[22]刘会,刘桐希,谢晟,等.重症与危重症甲型H1N1流感肺炎的影像学特点比较分析以及临床联系[J].实用放射学杂志,2017,33(1):47-50.
[23]Tandel K,Sharma S,Dash PK,et al.Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015[J].J Med Virol,2018,90(5):836-843.
[24]Thorlund K,Awad T,Boivin G,et al.Systematic review of influenza resistance to the neuraminidase inhibitors[J].BMC Infect Dis,2011(11):134.
[25]Abed Y,Tu V,Carbonneau J,et al.Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation,in vitro and in animal models[J].Antiviral Res,2018,159(9):26-34.
[26]Jarhult JD.Oseltamivir (Tamiflu○R) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans--a review[J].Infect Ecol Epidemiol,2012,2(10):3402.
[27]孙甲君,李琛,吴大玮,等.成人甲型H1N1流感伴呼吸衰竭18例分析[J].中华危重病急救医学,2010,22(3):156-160.
[28]Zangrillo A,Biondi-Zoccai G,Landoni G,et al.Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO[J].Crit Care,2013,17(1):R30.
[29]Sukhal S,Sethi J,Ganesh M,et al.Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis[J].Ann Card Anaesth,2017,20(1):14-21.
[30]Pappalardo F,Pieri M,Greco T,et al.Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score[J].Intensive Care Med,2013,39(2):275-281.

相似文献/References:

[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
 ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal Cancer[J].Medical Information,2018,(05):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]张林.围术期输血对胃癌根治术患者预后及免疫的影响[J].医学信息,2018,(01):94.[doi:10.3969/j.issn.1006-1959.2018.01.033]
 ZHANG Lin.Effect of Perioperative Blood Transfusion on Prognosis and Immunity of Patients with Radical Gastrectomy[J].Medical Information,2018,(05):94.[doi:10.3969/j.issn.1006-1959.2018.01.033]
[3]及预后罗华.白内障术后眼内炎的危险因素分析[J].医学信息,2018,(01):108.[doi:10.3969/j.issn.1006-1959.2018.01.040]
 LUO Hua.Risk Factors and Prognosis of Endophthalmitis after Cataract Surgery[J].Medical Information,2018,(05):108.[doi:10.3969/j.issn.1006-1959.2018.01.040]
[4]倪凤媛,李青山,刘兰芳,等.复发转移乳腺癌首发转移模式及预后影响因素[J].医学信息,2018,(12):1.[doi:10.3969/j.issn.1006-1959.2018.12.001]
 NI Feng-yuan,LI Qing-shan,LIU Lan-fang,et al.The First Metastatic Model of Metastatic Breast Cancer and the Influencing Factors of its Prognosis[J].Medical Information,2018,(05):1.[doi:10.3969/j.issn.1006-1959.2018.12.001]
[5]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
 WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,(05):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[6]李 光.替吉奥联合阿帕替尼治疗晚期胰腺癌的疗效分析[J].医学信息,2018,(16):87.[doi:10.3969/j.issn.1006-1959.2018.16.025]
 LI Guang.Therapeutic Effect of Tiggio Combined with Apatinib in the Treatment of Advanced Pancreatic Cancer[J].Medical Information,2018,(05):87.[doi:10.3969/j.issn.1006-1959.2018.16.025]
[7]刘 锌,杜 斌,孙光权,等.血清岩藻糖苷酶在股骨头坏死保髋患者预后判断中的临床价值[J].医学信息,2018,(19):64.[doi:10.3969/j.issn.1006-1959.2018.19.021]
 LIU Xin,DU Bin,SUN Guang-quan,et al.Clinical Value of Serum Fucosidase in Predicting the Prognosis of Hip Preservation patients with Osteonecrosis of Femoral Head[J].Medical Information,2018,(05):64.[doi:10.3969/j.issn.1006-1959.2018.19.021]
[8]史世华,马天洪,山家玥,等.中药汤剂联合西药口服治疗痛风性关节炎预后的Meta分析[J].医学信息,2018,(19):131.[doi:10.3969/j.issn.1006-1959.2018.19.039]
 SHI Shi-hua,MA Tian-hong,SHAN Jia-yue,et al.Meta-analysis of the Prognosis of Oral Traditional Chinese Medicine Decoction Combined with Western Medicine in the Treatment of Gouty Arthritis[J].Medical Information,2018,(05):131.[doi:10.3969/j.issn.1006-1959.2018.19.039]
[9]张艳萍,曹 玉,孙国平.服用阿司匹林对乳腺癌患者生存获益的Meta分析[J].医学信息,2018,(20):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
 ZHANG Yan-ping,CAO Yu,SUN Guo-ping.Meta Analysis of the Survival Benefit of Patients with Breast Cancer Treated with Aspirin[J].Medical Information,2018,(05):72.[doi:10.3969/j.issn.1006-1959.2018.20.021]
[10]谢世宇,程贤高,丁 丹.PICU危重患儿预后危险因素分析[J].医学信息,2018,(22):107.[doi:10.3969/j.issn.1006-1959.2018.22.029]
 XIE Shi-yu,CHENG Xian-gao,DING Dan.Analysis of Prognostic Risk Factors in Critically Ill Children with PICU[J].Medical Information,2018,(05):107.[doi:10.3969/j.issn.1006-1959.2018.22.029]

更新日期/Last Update: 2019-03-01